Literature DB >> 17456763

Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and annexin A2.

Elena Ortiz-Zapater1, Sandra Peiró, Oriol Roda, Josep M Corominas, Susana Aguilar, Coral Ampurdanés, Francisco X Real, Pilar Navarro.   

Abstract

Tissue plasminogen activator (tPA) is overexpressed in pancreatic ductal carcinoma and is involved in tumor progression. This effect is probably mediated through the activation of angiogenesis, cell invasion, and cell proliferation. Previous studies support the notion that the effects of tPA on cell invasion require its proteolytic activity. Here, we report the molecular mechanism responsible for the proliferative effects of tPA on pancreatic tumor cells. tPA activates the extracellular signal-regulated kinase 1/2 signaling pathway in a manner that is independent of its catalytic activity. We also show that at least two membrane receptors, epidermal growth factor receptor and annexin A2, which are overexpressed in pancreatic cancer, are involved in the transduction of tPA signaling in pancreatic tumors. This observation suggests the establishment of an amplification loop in tumor cell proliferation. Double immunofluorescence experiments showed co-localization of tPA/epidermal growth factor receptor and tPA/annexin A2 in pancreas cancer cells. These results add novel insights into the non-catalytic functions of tPA in cancer and the molecular mechanisms behind the effects of this protease on cell proliferation, including a role for epidermal growth factor receptor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17456763      PMCID: PMC1854952          DOI: 10.2353/ajpath.2007.060850

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  74 in total

Review 1.  Focus on pancreas cancer.

Authors:  Elizabeth M Jaffee; Ralph H Hruban; Marcia Canto; Scott E Kern
Journal:  Cancer Cell       Date:  2002-07       Impact factor: 31.743

Review 2.  Epidermal growth factor receptor targeting in cancer.

Authors:  John Mendelsohn; Jose Baselga
Journal:  Semin Oncol       Date:  2006-08       Impact factor: 4.929

3.  Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer.

Authors:  M J Duffy; D Reilly; C O'Sullivan; N O'Higgins; J J Fennelly; P Andreasen
Journal:  Cancer Res       Date:  1990-11-01       Impact factor: 12.701

4.  Immunohistochemical evidence of urokinase-type plasminogen activator in primary and metastatic tumors of pulmonary adenocarcinoma.

Authors:  T Oka; T Ishida; T Nishino; K Sugimachi
Journal:  Cancer Res       Date:  1991-07-01       Impact factor: 12.701

5.  In vitro properties of human melanoma cells metastatic in nude mice.

Authors:  D Herlyn; D Iliopoulos; P J Jensen; A Parmiter; J Baird; H Hotta; K Adachi; A H Ross; J Jambrosic; H Koprowski
Journal:  Cancer Res       Date:  1990-04-15       Impact factor: 12.701

6.  The secretion of plasminogen activators by human myeloid leukemic cells in vitro.

Authors:  E L Wilson; P Jacobs; E B Dowdle
Journal:  Blood       Date:  1983-03       Impact factor: 22.113

7.  Stimulation of tissue type plasminogen activator by leukaemic cell homogenates.

Authors:  H Wada; Y Kumeda; Z Ogasawara; K Minamikawa; Y Wakita; T Nakase; T Kaneko; M Ohiwa; S Kageyama; T Kobayashi
Journal:  Blood Coagul Fibrinolysis       Date:  1993-08       Impact factor: 1.276

8.  Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha.

Authors:  M Korc; B Chandrasekar; Y Yamanaka; H Friess; M Buchier; H G Beger
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

9.  The epidermal growth factor receptor in human pancreatic cancer.

Authors:  N R Lemoine; C M Hughes; C M Barton; R Poulsom; R E Jeffery; G Klöppel; P A Hall; W J Gullick
Journal:  J Pathol       Date:  1992-01       Impact factor: 7.996

10.  Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness.

Authors:  Y Yamanaka; H Friess; M S Kobrin; M Buchler; H G Beger; M Korc
Journal:  Anticancer Res       Date:  1993 May-Jun       Impact factor: 2.480

View more
  31 in total

1.  Tissue Plasminogen Activator: Side Effects and Signaling.

Authors:  Ling Lin; Kebin Hu
Journal:  J Drug Des Res       Date:  2014-09-25

2.  Grassystatins D-F, Potent Aspartic Protease Inhibitors from Marine Cyanobacteria as Potential Antimetastatic Agents Targeting Invasive Breast Cancer.

Authors:  Fatma H Al-Awadhi; Brian K Law; Valerie J Paul; Hendrik Luesch
Journal:  J Nat Prod       Date:  2017-10-31       Impact factor: 4.050

3.  Clathrin mediates endocytosis of progastrin and activates MAPKs: role of cell surface annexin A2.

Authors:  Shubhashish Sarkar; Carla Kantara; Pomila Singh
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-01-12       Impact factor: 4.052

4.  Progastrin Peptides Increase the Risk of Developing Colonic Tumors: Impact on Colonic Stem Cells.

Authors:  Pomila Singh; Shubhashish Sarkar; Carla Kantara; Carrie Maxwell
Journal:  Curr Colorectal Cancer Rep       Date:  2012-12

5.  Ligand binding to LRP1 transactivates Trk receptors by a Src family kinase-dependent pathway.

Authors:  Yang Shi; Elisabetta Mantuano; Gen Inoue; W Marie Campana; Steven L Gonias
Journal:  Sci Signal       Date:  2009-04-28       Impact factor: 8.192

6.  Binding of tissue-type plasminogen activator to the glucose-regulated protein 78 (GRP78) modulates plasminogen activation and promotes human neuroblastoma cell proliferation in vitro.

Authors:  Mario Gonzalez-Gronow; Cristian Farias Gomez; Gustaaf G de Ridder; Rupa Ray; Salvatore V Pizzo
Journal:  J Biol Chem       Date:  2014-07-24       Impact factor: 5.157

7.  Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma.

Authors:  Wenwei Chen; Lihong Chen; Zhixiong Cai; Dong Liang; Bixing Zhao; Yongyi Zeng; Xiaolong Liu; Jingfeng Liu
Journal:  Tumour Biol       Date:  2016-01-16

8.  Activation of NF-kappaB is required for mediating proliferative and antiapoptotic effects of progastrin on proximal colonic crypts of mice, in vivo.

Authors:  S Umar; S Sarkar; S Cowey; P Singh
Journal:  Oncogene       Date:  2008-06-02       Impact factor: 9.867

9.  Activated protein C enhances cell motility of endothelial cells and MDA-MB-231 breast cancer cells by intracellular signal transduction.

Authors:  Mark W Gramling; Lea M Beaulieu; Frank C Church
Journal:  Exp Cell Res       Date:  2009-11-03       Impact factor: 3.905

10.  S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility.

Authors:  T Nedjadi; N Kitteringham; F Campbell; R E Jenkins; B K Park; P Navarro; F Ashcroft; A Tepikin; J P Neoptolemos; E Costello
Journal:  Br J Cancer       Date:  2009-09-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.